Spotlight on the Expanding Role of miR-647 in Human Cancers

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• MicroRNAs (miRNAs) are small, non-coding RNAs regulating gene expression epigenetically.
• miRNAs play crucial roles in cellular processes and are recognized as potential cancer biomarkers.
• Aberrant miRNA expression is linked to various human diseases, including cancer.

Purpose of the Study:

• To review the molecular mechanisms, target genes, and clinical significance of miR-647 in diverse cancers.
• To consolidate evidence on miR-647's role as a potential biomarker and therapeutic target in oncology.

Main Methods:

• Literature review of studies investigating miR-647 in various cancer types.
• Analysis of reported data on miR-647 expression levels, molecular functions, and clinical implications.
• Synthesis of findings regarding miR-647's role in tumorigenesis and its potential as a therapeutic target.

Main Results:

• miR-647 exhibits aberrant expression in numerous cancers, including bladder, cervical, colorectal, gastric, glioma, hepatocellular, non-small cell lung, ovarian, and prostate cancers.
• miR-647 can act as either an oncogene or a tumor suppressor, influencing cancer cell proliferation, migration, and invasion.
• Serum miR-647 levels correlate with decreased overall survival and disease progression.

Conclusions:

• miR-647 is a significant regulator in various cancers, impacting cell cycle pathways and tumor progression.
• miR-647 holds promise as a biomarker for cancer detection, prognosis, and therapeutic response assessment.
• Modulating miR-647 expression presents a potential therapeutic strategy for solid tumors, with antitumor drugs targeting its expression.